In Silico In Vitro and In Vivo Memory Enhancing activity of certain commercially available Flavonoids in Scopolamine and Aluminium Induced Learning Impairment in Mice

dc.contributor.guideAsok Kumar K
dc.coverage.spatial
dc.creator.researcherMadeswaran A
dc.date.accessioned2021-09-03T05:12:45Z
dc.date.available2021-09-03T05:12:45Z
dc.date.awarded
dc.date.completed2017
dc.date.registered
dc.description.abstractAlzheimer s disease is a neurodegenerative disorder associated with a decline in cognitive abilities. The deficiency of acetylcholine is one of the characteristics of AD and responsible for most of its symptoms, such as a decline in memory and cognition. As a consequence of its role as a target for AD therapy, AChE is one of the most studied target in the Alzheimer s field and the vast majority of reports in the field relate with treatment strategies associated with the use of AChE inhibitors. Despite the severity and high prevalence of this disease, the allopathic system of medicine is yet to provide a satisfactory drug candidate. Hence, the present study was focused on exploration of the memory enhancing activity of the flavonoids in scopolamine and aluminium-induced learning impairment in mice. The current study suggests that the flavonoids, baicalein and scopoletin possessed excellent binding interactions and docking score with AChE and BuChE enzymes than the standard (donepezil) in in silico studies. The in silico studies addressed the flavonoids stability against AChE and BuChE (protein-ligand complex) by molecular dynamic simulation. The in silico studies is actually an added advantage to screen the ChE enzyme inhibition. Two hundred and forty five compounds were selected and screened in the computational studies and among these compounds 20 flavonoids have been selected for the in vitro enzyme inhibition studies based on their docking results. In conclusion, it has been clearly demonstrated that the approach utilized in this study is successful in finding novel anti-alzhiemer s drugs. In particular, higher dose of scopoletin and baicalein, showed excellent neuroprotective effects against in silico, in vitro enzyme inhibitory and in vivo acute scopolamine and chronic AlCl3 induced learning impairment models. Hence, scopoletin and baicalein could be considered as a therapeutic agent to prevent or slow down the development of neurodegenerative diseases such as AD. newline
dc.description.note
dc.format.accompanyingmaterialNone
dc.format.dimensions
dc.format.extent303
dc.identifier.urihttp://hdl.handle.net/10603/338952
dc.languageEnglish
dc.publisher.institutionDepartment of Pharmacy
dc.publisher.placeChennai
dc.publisher.universityThe Tamil Nadu Dr. M.G.R. Medical University
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordAluminium Induced Learning Impairment
dc.subject.keywordAlzheimer s disease
dc.subject.keywordFlavonoids
dc.subject.keywordMemory Enhancing activity
dc.subject.keywordScopolamine
dc.titleIn Silico In Vitro and In Vivo Memory Enhancing activity of certain commercially available Flavonoids in Scopolamine and Aluminium Induced Learning Impairment in Mice
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 13
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
5.88 MB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_certificate.pdf
Size:
5.88 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_preliminary pages.pdf
Size:
5.88 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_chapter 1.pdf
Size:
5.89 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 2.pdf
Size:
5.88 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: